Neuromodulation devices are medical devices used to curb chronic diseases and are used for effective pain management. The devices function by producing electrical impulses to create paraesthesia or numbness in the target area. Neuromodulation device technology is a relatively new concept and is proving to be extremely effective in managing chronic diseases. Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous system for therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous system, the autonomic nervous system and the deep cell nuclei of the brain, resulting in modulation of their activity. It can be used to treat movement disorders, spasticity, epilepsy as well as pain syndromes.
The global neuromodulation devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global neuromodulation devices market segmentation is based on technology (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices).
The global global neuromodulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global neuromodulation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global neuromodulation devices market and included in this report are Boston Scientific Group, Cyberonics, Nevro, Medtronic, Neuronetics Inc., St. Jude Medical, and Uroplasty.